Aclaris Therapeutics, Inc. (ACRS)
3.36
+0.09
(+2.75%)
USD |
NASDAQ |
Dec 11, 16:00
3.39
+0.03
(+0.89%)
After-Hours: 18:13
Aclaris Therapeutics EPS Diluted (Quarterly): -0.1192 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Puma Biotechnology, Inc. | 0.1736 |
| Xencor, Inc. | -0.081 |
| Vivos Therapeutics, Inc. | -0.4925 |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.61M |
| Revenue (Quarterly) | 3.299M |
| Total Expenses (Quarterly) | 17.91M |
| Enterprise Value | 260.62M |
| Gross Profit Margin (Quarterly) | 25.77% |
| Profit Margin (Quarterly) | -443.0% |
| Earnings Yield | -41.11% |
| Normalized Earnings Yield | -22.04 |